Latest Macular degeneration Stories
TARRYTOWN, N.Y., Aug. 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Brand offers highly effective supplements for improved eye and total body health. Boca Raton, FL (PRWEB) August 05, 2014 Doctor’s Advantage Products,
Understanding eye diseases is tricky enough.
DME is the third approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
A new study from the Mainz University Medical Center demonstrates that education and behavior play as large a role in the development of myopia, or nearsightedness, as genetic factors do.
TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment
Funding Critical on Diseases Now Affecting Baby Boomers CLARKSBURG, Md., July 11, 2014 /PRNewswire/ -- BrightFocus
First clinical trial of integrated approach underlines need for inclusion of behavior activation therapy in low vision rehabilitation SAN FRANCISCO, July 9, 2014 /PRNewswire-USNewswire/ --
- A bereavement by loss of parents or children; the state of being orbate; orbation.